Insulin Lispro
Pricing Report NDC 66733-822-59

Latest NADAC: $10.18427 per ML · Effective Jul 20, 2022 · Est. package price $152.76 (15 ML)
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Insulin Lispro Kwikpen (NDC 66733-822-59) is $10.18427 per ML. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jul 20, 2022.

As a provided by Imclone Llc, this medication is distributed in a 5 SYRINGE in 1 CARTON / 3 mL in 1 SYRINGE (66733-822-01) configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$10.18427
Per ML

Pricing Unit
Per ML Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Jul 20, 2022
Billable Units
15 ML
Estimated Package Price
$152.76
Data Status
As of Jul 27, 2022
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
66733-822-59
Description
5 SYRINGE in 1 CARTON / 3 mL in 1 SYRINGE (66733-822-01)
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Aug 2019, the NADAC wholesale price for (NDC ) has moved within a range of $10.17053 to $16.99861 per ML. Over this 2 years and 10 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$10.1705 - $16.9986
Market Volatility
67.14% Variance
Latest Trend
0.14%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Jul 20, 2022 $10.18427 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jun 22, 2022 $10.17053 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
May 18, 2022 $10.17299 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Apr 20, 2022 $10.18073 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Mar 23, 2022 $10.18483 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jan 12, 2022 $10.18141 MLC/I - Chain or Independent PharmacyCode 3, 5, 6G - Generic
Jan 12, 2022 $10.18141 MLC/I - Chain or Independent PharmacyCode 4, 5, 6G - Generic
Dec 22, 2021 $16.96903 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Nov 17, 2021 $16.90701 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Oct 20, 2021 $16.97407 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Sep 22, 2021 $16.97490 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Aug 18, 2021 $16.95893 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026